Aster vs Immunefi — how do they compare? Aster trades at Rp10,733 (market cap Rp28,96T, Rp577,35M 24h volume), while Immunefi trades at Rp24.67 (market cap Rp27,03M, Rp39,91M 24h volume). The key difference: Aster is far larger — about 1071402.1× Immunefi's market cap, and Aster's circulating supply is 2,7B / 8B ASTER (34%) versus 873,4M / 10B IMU (9%) for Immunefi. Which is the better fit depends on your goals — on Pluang, investors hold Aster for 23 Days and Immunefi for 5 Days on average.
| ASTER | IMU | |
|---|---|---|
Market Cap | Rp28,96T | Rp27,03M |
Volume (24h) | Rp577,35M | Rp39,91M |
Circulating Supply | 2,7B / 8B ASTER (34%) | 873,4M / 10B IMU (9%) |
Typical Hold Time | 23 Days | 5 Days |
Signals from Pluang's Aura AI — not financial advice
Aster is currently trading at Rp10,735 with a market cap of Rp28.98 trillion, showing bearish technical signals with moving averages indicating selling pressure while oscillators remain neutral. The token has 34% circulating supply with 2.7 million ASTER in circulation out of 8 million maximum. Current price sits between support at Rp10,693 and resistance at Rp10,758, with average hold time of 23 days suggesting moderate trader confidence.
Overall outlook remains cautious with bearish technicals outweighing neutral indicators. Key opportunity lies in potential bounce from support levels, while major risks include limited liquidity depth and the token's relatively low circulation rate affecting market dynamics. Investors should monitor volume patterns and network adoption metrics closely.
Immunefi (IMU) presents a unique crypto asset with a modest market cap of Rp27.03M and only 9% circulating supply, indicating significant token lockup. The 5-day average hold time suggests short-term trading activity. Current technical analysis is limited due to missing price data, but the low circulation rate and small market cap point to high volatility potential. Recent news coverage appears to focus on corporate equity analysis rather than blockchain fundamentals, creating information asymmetry for crypto investors.
Overall outlook remains speculative with limited fundamental data. Key opportunity lies in potential token unlocks and ecosystem growth, while major risks include extreme volatility from low liquidity, regulatory uncertainty, and lack of clear crypto-specific utility. Investors should approach with caution given the asset's early stage and limited market data availability.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Aster is a next-generation decentralized exchange combining Perpetual and Spot trading in one on-chain platform. It supports advanced features like stock perpetuals and grid trading across multiple chains, while enabling asBNB and USDF as collateral for superior capital efficiency. Built on Aster Chain and backed by YZi Labs, Aster powers fast, flexible, and community-first DeFi with the ASTER token driving governance and rewards.
Read more on ASTER →Immunefi is a security-focused ecosystem token designed to reward contributions to blockchain safety. It aligns protocols, researchers, and communities through bug bounties, staking, and governance incentives. The ecosystem also integrates AI to enhance threat detection and scale protection as the on-chain economy grows.
Read more on IMU →